Pfizer has the mission to fund programs that provide public benefit, advance medical care, and can improve patient outcomes. Their researchers preform 25,000 clinical tests everyday for pharmaceutical development and innovations.
Pfizer is a partner with the BaseLaunch startup accelerator. The BaseLaunch program receives applications in the fields of therapeutics, diagnostics, digital healthcare, healthcare services, therapeutic platforms, and medical technology.
Insilico Medicine and Pfizer entered into a research collaboration agreement. The agreement allows Pfizer to utilize Insilico Medicine's machine learning technology and Pandomics Discovery Platform to research potential therapeutic targets for a variety of diseases.
AMRA Medical and Pfizer's partnership works to investigate body fat distribution and muscle composition in a range of diseases using the UK Biobank registry. The partnership involves the body composition analysis of 100,000 individuals.
Pfizer's partnership with CytoReason gives them access to CytoReason's machine learning platform for drug discovery and development.
XtalPi Inc. and Pfizer's research collaboration focuses on developing a hybrid physics-and artificial intelligence-powered software platform for accurate molecular modeling of small molecules. The platform is intended to advance both companies capabilities in drug design and solid-form selection.
Pfizer and Distributed Bio entered an agreement to license Distributed Bio's SuperHuman Platform to Pfizer. The SuperHuman 2.0 antibody discovery platform will allow Pfizer to utilize the antibody library for screening activities against Pfizer-selected targets.
Domain Therapeutics and Pfizer entered into a collaboration agreement to asses Domain Therapeutics's bioSensAll platform. The bioSensAll platform defines signaling signatures for each wild-type and mutant receptors. Pfizer aims to use the platform to assess the impact of mutations on different signaling pathways engaged by g protein-coupled receptors.
Pfizer announced that they have identified certain antiviral compounds that are under development which could be effective in treating the novel coronavirus SARS-CoV-2 responsible for COVID-19. They may enter a partnership with a third party company to screen and identify potential compounds by the end of March, 2020 in order to begin testing in April, 2020.
Pfizer is partnered with BioNTech for co-development and distribution of an mRNA vaccine against SARS-CoV-2 called BNT162.
The European Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer, which provides for the initial purchase of 200 million doses on behalf of all EU Member States, plus an option to request up to a further 100 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19. Member States can decide to donate the vaccine to lower and middle-income countries or to re-direct it to other European countries.
A molecular diagnostics company developing novel blood-based early detection and disease monitoring tests based on analyzing circulating cell-free messenger RNA (cf-mRNA) in blood samples to monitor organ function.
A genetic medicines company in Massachusetts that focuses on patients suffering from rare genetic diseases.
Trillium Therapeutics is a biotechnology company developing cancer immunotherapies.
Imara is a Cambridge, Massachusetts-based biotechnology company.
Amplyx Pharmaceuticals, Inc. is a preclinical stage company focusing on the development of small molecule drugs.
SpringWorks Therapeutics is a Stamford, Connecticut-based company founded in 2017 by Lara S. Sullivan.
FoRx Therapeutics is a Basel-based biotechnology company developing a drug discovery platform for cancer drugs.
Vivet Therapeutics is a France-based company.
Arrakis Therapeutics is a Waltham, Massachusetts-based company.
Strata is a Lake Forest, California-based company founded in 1995.
Aquinnah Pharmaceuticals is a Cambridge, Massachusetts-based company.
Abdalrahman Mekky, CMA
Abraham Svinkelstin, PMP, MS, MS, CSSGB
Alec Robert Gilarde
Alexander H. Buell
Breaking the Rules of Biology to Beat Rare Genetic Disease | Pfizer
Our Science: Pharmaceutical Development | Pfizer | Pfizer
Pfizer | Crunchbase
Pfizer's Core Values of Social Responsibility and Philanthropy | Pfizer
What to Know About Coronavirus -- COVID-19 Explained | Pfizer
Documentaries, videos and podcasts
New York, New York, United States
Medical, healthcare, biotechnology, and pharmaceutical products and services
- BiotechnologyBiotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.
- Cluster: COVID-19A cluster of topics related to COVID-19. COVID-19 is the abbreviated name for coronavirus disease 2019, a respiratory disease caused by a novel coronavirus strain called SARS-CoV-2. COVID-19 was first detected in Wuhan City, China and the outbreak was declared a pandemic on March 11, 2020 by the WHO.
- CoronavirusCDC Coronavirus: Coronaviruses are common throughout the world. They can infect people and animals. Five different coronaviruses can infect people and make them sick. They usually cause mild to moderate upper-respiratory illness.
- HealthcareDiagnosis, treatment and prevention of disease, illness, and injury